OMOP
Observational Medical Outcomes Partnership
Public-private partnership involving the FDA, multiple pharmaceutical companies, and healthcare providers. OMOP was developed by the OHDSI consortium to guide the appropriate use of observational healthcare databases for studying the risks and benefits of medical products.

